147 related articles for article (PubMed ID: 27514543)
1. The interaction of Wnt-11 and signalling cascades in prostate cancer.
Koushyar S; Grant GH; Uysal-Onganer P
Tumour Biol; 2016 Oct; 37(10):13049-13057. PubMed ID: 27514543
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
3. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.
Liu XH; Kirschenbaum A; Yao S; Liu G; Aaronson SA; Levine AC
Cancer Res; 2007 Jun; 67(12):5747-53. PubMed ID: 17575141
[TBL] [Abstract][Full Text] [Related]
4. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
5. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.
Thiele S; Rauner M; Goettsch C; Rachner TD; Benad P; Fuessel S; Erdmann K; Hamann C; Baretton GB; Wirth MP; Jakob F; Hofbauer LC
J Cell Biochem; 2011 Jun; 112(6):1593-600. PubMed ID: 21344486
[TBL] [Abstract][Full Text] [Related]
8. PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer.
Vela I; Morrissey C; Zhang X; Chen S; Corey E; Strutton GM; Nelson CC; Nicol DL; Clements JA; Gardiner EM
Clin Exp Metastasis; 2014 Feb; 31(2):199-211. PubMed ID: 24162257
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
Pashirzad M; Shafiee M; Khazaei M; Fiuji H; Ryzhikov M; Soleimanpour S; Hesari A; Avan A; Hassanian SM
J Cell Physiol; 2019 Feb; 234(2):1237-1247. PubMed ID: 30191954
[TBL] [Abstract][Full Text] [Related]
11. WNT signalling in prostate cancer.
Murillo-Garzón V; Kypta R
Nat Rev Urol; 2017 Nov; 14(11):683-696. PubMed ID: 28895566
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM
Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198
[TBL] [Abstract][Full Text] [Related]
13. Inhibition on JNK Mimics Silencing of Wnt-11 Mediated Cellular Response in Androgen-Independent Prostate Cancer Cells.
Arisan ED; Rencuzogullari O; Keskin B; Grant GH; Uysal-Onganer P
Biology (Basel); 2020 Jun; 9(7):. PubMed ID: 32605008
[TBL] [Abstract][Full Text] [Related]
14. Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
Katoh M; Katoh M
Int J Mol Med; 2007 Sep; 20(3):405-9. PubMed ID: 17671748
[TBL] [Abstract][Full Text] [Related]
15. VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells.
Fernández-Martínez AB; Carmena MJ; Bajo AM; Vacas E; Sánchez-Chapado M; Prieto JC
Cell Signal; 2015 Feb; 27(2):236-44. PubMed ID: 25446255
[TBL] [Abstract][Full Text] [Related]
16. The WNT system: background and its role in bone.
Lerner UH; Ohlsson C
J Intern Med; 2015 Jun; 277(6):630-49. PubMed ID: 25845559
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
18. Cushioning the cartilage: a canonical Wnt restricting matter.
Monteagudo S; Lories RJ
Nat Rev Rheumatol; 2017 Nov; 13(11):670-681. PubMed ID: 29021569
[TBL] [Abstract][Full Text] [Related]
19. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
20. The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?
ter Horst P; Smits JF; Blankesteijn WM
Acta Physiol (Oxf); 2012 Jan; 204(1):110-7. PubMed ID: 21624093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
